Cargando…
Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients
Cancer is a complex disease that is constantly evolving. It is now the most common cause of death in Europe after cardiovascular diseases. There are inequalities among European countries, potentially unsustainable healthcare systems impacting quality of cancer care and increasing number of patients...
Autores principales: | Negrouk, Anastassia, Lacombe, Denis, Cardoso, Fatima, Morin, Franck, Carrasco, Eva, Maurel, Joan, Maibach, Rudolf, Aranda, Enrique, Marais, Richard, Stahel, Rolf A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634488/ https://www.ncbi.nlm.nih.gov/pubmed/29021919 http://dx.doi.org/10.1136/esmoopen-2017-000187 |
Ejemplares similares
-
Current models, challenges and best practices for work conducted between European academic cooperative groups and industry
por: Stahel, Rolf A, et al.
Publicado: (2020) -
Making Change Happen in Health
por: Horgan, Denis, et al.
Publicado: (2017) -
The Safeguards of Maternity Benefit
Publicado: (1913) -
International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
por: Shash, Emad, et al.
Publicado: (2013) -
Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
por: Lalova, Teodora, et al.
Publicado: (2020)